The DOI matches its Crossref record.
The Role of Ethnopharmacology in Drug Development
Abstract
There are 119 drugs of known structure that are still extracted from higher plants and used globally in allopathic medicine. About 74% of these were discovered by chemists who were attempting to identify the chemical substances in the plants that were responsible for their medical uses by humans. These 119 plant-derived drugs are produced commercially from less than 90 species of higher plants. Since there are at least 250,000 species of higher plants on earth, it is logical to presume that many more useful drugs will be found in the plant kingdom if the search for these entities is carried out in a logical and systematic manner. The first and most important stage in a drug development programme using plants as the starting material should be the collection and analysis of information on the use(s) of the plant(s) by various indigenous cultures. Ethnobotany, ethnomedicine, folk medicine and traditional medicine can provide information that is useful as a 'pre-screen' to select plants for experimental pharmacological studies. Examples are given to illustrate how data from ethnomedicine can be analysed with the aim of selecting a reasonable number of plants to be tested in bioassay systems that are believed to predict the action of these drugs in humans. The ultimate goal of ethnopharmacology should be to identify drugs to alleviate human illness via a thorough analysis of plants alleged to be useful in human cultures throughout the world. Problems and prospects involved in attaining this goal are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The value of plants used in traditional medicine for drug discovery.
Fabricant, D. S., & Farnsworth, N. R. (2001) · Environmental Health Perspectives · doi:10.1289/ehp.01109s169 · Cited by 2,038
Self-citationMedicinal plants in Mexico: healers' consensus and cultural importance
Heinrich, M., Ankli, A., Frei, B., Weimann, C., & Sticher, O. (1998) · Social Science & Medicine · doi:10.1016/s0277-9536(98)00181-6 · Cited by 1,283
Natural products in anticancer therapy
da Rocha, A. (2001) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(01)00063-7 · Cited by 604
The pharmaceutical industry and natural products: historical status and new trends
David, B., Wolfender, J.-L., & Dias, D. A. (2015) · Phytochemistry Reviews · doi:10.1007/s11101-014-9367-z · Cited by 579
Traditional herbal drugs of Bulamogi, Uganda: plants, use and administration
Tabuti, J. R. S., Lye, K. A., & Dhillion, S. S. (2003) · Journal of Ethnopharmacology · doi:10.1016/s0378-8741(03)00161-2 · Cited by 493
Biodiversity, traditional medicine and public health: where do they meet?
Alves, R. R., & Rosa, I. M. (2007) · Journal of Ethnobiology and Ethnomedicine · doi:10.1186/1746-4269-3-14 · Cited by 418
Immunomodulatory and Antimicrobial Effects of Some Traditional Chinese Medicinal Herbs: A Review
Tan, B., & Vanitha, J. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043365161 · Cited by 412
Traditional management of ear, nose and throat (ENT) diseases in Central Kenya
Njoroge, G. N., & Bussmann, R. W. (2006) · Journal of Ethnobiology and Ethnomedicine · doi:10.1186/1746-4269-2-54 · Cited by 362
Natural products for human health: an historical overview of the drug discovery approaches
Bernardini, S., Tiezzi, A., Laghezza Masci, V., & Ovidi, E. (2018) · Natural Product Research · doi:10.1080/14786419.2017.1356838 · Cited by 355
Mans, D. R. A., Rocha, A. B., & Schwartsmann, G. (2000) · The Oncologist · doi:10.1634/theoncologist.5-3-185 · Cited by 254
Marine organisms and other novel natural sources of new cancer drugs
Schwartsmann, G. (2000) · Annals of Oncology · doi:10.1093/annonc/11.suppl_3.235 · Cited by 81
Metadata
- Authors
- Farnsworth, N. R.
- Venue
- Novartis Foundation Symposia
- Publisher
- Wiley
- Published
- 2007-09-28
- Volume
- 154
- Pages
- 2-21
- ISSN
- 1528-2511 (ISSN-L)
- 1935-4657
- OpenAlex
- W1484501363
- Cited by
- 204
- References
- 0
- Type
- other
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.